NYSE · Healthcare
ACCESS Newswire Inc. (ACCS)
As-reported financials and recent SEC filings for ACCESS Newswire Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$22.6M
Net income
$4.3M
Net margin
19.0%
Diluted EPS
$1.11
ROE
14.1%
P/E (TTM)
—
Market cap
—
Debt / equity
0.1×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $22.6M | $23.1M | $24.5M | $23.5M | $21.9M |
| Gross profit | $17.3M | $17.4M | $18.9M | $17.8M | $16.1M |
| Operating income | $-1.9M | $-16.3M | $-2.7M | $2.7M | $3.7M |
| Net income | $4.3M | $-10.8M | $766,000 | $1.9M | $3.3M |
| Diluted EPS | $1.11 | $-2.82 | $0.00 | $0.51 | $0.84 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-07-01
View on EDGAR →8-K2026-07-01
View on EDGAR →42026-06-30
View on EDGAR →42026-06-24
View on EDGAR →42026-06-22
View on EDGAR →42026-05-29
View on EDGAR →42026-05-27
View on EDGAR →SCHEDULE 13D/A2026-05-21
View on EDGAR →Largest Healthcare peers
Go deeper on ACCS
Search ACCESS Newswire Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.